Exelixis continues to outperform Alnylam Pharmaceuticals by 9.0% year to date

Media coverage

• Title	Exelixis continues to outperform Alnylam Pharmaceuticals by 9.0% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	4/21/25
  Persons	George Poste

• Title	Exelixis continues to outperform Amgen by 2.3% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	4/21/25
  Persons	George Poste

• Title	Exelixis continues to outperform BioMarin Pharmaceutical by 18.6% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	4/21/25
  Persons	George Poste

• Title	Exelixis continues to outperform Biogen by 31.1% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	4/21/25
  Persons	George Poste